Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2019 - 2020)
Burning Rock Biotech (BNR) posted quarterly Non-Current Deffered Revenue of $39684.9 for Q4 2020, down 71.78% year-over-year from $140603.8 in Q1 2020, and up 1.76% on a QoQ basis from $39000.0 in Q3 2020.
Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2019 - 2020) Analysis & Trends
Burning Rock Biotech (BNR) has reported Non-Current Deffered Revenue for 2 consecutive years, with $39684.9 the latest figure, recorded in Q4 2020.
- In Q4 2020, Non-Current Deffered Revenue fell 71.78% year-over-year to $39684.9; the TTM figure through Dec 2020 stood at $39684.9 (down 71.78% YoY), while the FY2020 annual figure was $40000.0, down 72.13% from the prior year.
- Non-Current Deffered Revenue came in at $39684.9 for Q4 2020 at Burning Rock Biotech, up from $39000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $140603.8 in Q4 2019, with the low at $37000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 17.00 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Burning Rock Biotech | 748.66 Mn | 683.48 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 39,684.94 |
| Sep 30, 2020 | 39,000.00 |
| Jun 30, 2020 | 37,000.00 |
| Dec 31, 2019 | 140,603.84 |